Hydrophobically Modified Chitosan in Biomedical Applications: Great Expectations vs. Translational Reality
Agnieszka Piegat, Agata Goszczyńska, Agata Niemczyk · 2026
Read Hydrophobically Modified Chitosan in Biomedical Applications: Great Expectations vs. Translational Reality by Agnieszka Piegat, Agata Goszczyńska, Agata Niemczyk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13468380.txt.
Description
Agnieszka Piegat, Agata Goszczyńska, and Agata Niemczyk argue in a 2026 perspective that modified chitosan is failing to reach the clinic for practical rather than biological reasons. Their subject is a chitosan variant whose chains carry water-hating groups, a much-studied biomaterial from crustacean shells. The material carries both water-loving and water-hating parts, so it self-assembles into carriers for drugs, antimicrobials, and tissue scaffolds, with plenty of promising lab results. Yet very few products have advanced toward real medical use.
The authors trace the bottleneck to results others cannot repeat, loose structure checks, and scant care for process design and factory scale-up. Their piece follows the material from chemical modification through self-assembly to formulation, showing where design and process choices decide reliability. They urge standard checks and shared write-up rules, the plain fixes they say translation actually needs.
Catalog record
| CREATOR | Agnieszka Piegat, Agata Goszczyńska, Agata Niemczyk |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |